{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:58:32Z","timestamp":1793059112917,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T00:00:00Z","timestamp":1498608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"CGBio Inc"},{"name":"BioAlpha Inc"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thespinejournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Spine Journal"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.spinee.2017.06.023","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T21:45:15Z","timestamp":1498254315000},"page":"1866-1874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Efficacy of Escherichia coli -derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial"],"prefix":"10.1016","volume":"17","author":[{"given":"Jae Hwan","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2141-0266","authenticated-orcid":false,"given":"Jae Hyup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Sup","family":"Yeom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong-Soon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Hyoung","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Ju","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Bok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon-Ki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoungmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Soo","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Dong","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.spinee.2017.06.023_bib0010","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/01.bsd.0000112045.36255.83","article-title":"Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment","volume":"18","author":"Sasso","year":"2005","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.spinee.2017.06.023_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12891-015-0861-2","article-title":"The fusion rate of demineralized bone matrix compared with autogenous iliac bone graft for long multi-segment posterolateral spinal fusion","volume":"17","author":"Fu","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.spinee.2017.06.023_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5312\/wjo.v5.i1.30","article-title":"Use of demineralized bone matrix in spinal fusion","volume":"18","author":"Tilkeridis","year":"2014","journal-title":"World J Orthop"},{"key":"10.1016\/j.spinee.2017.06.023_bib0025","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3171\/2009.6.SPINE08669","article-title":"Osteoinductive bone graft substitutes for lumbar fusion: a systematic review","volume":"11","author":"Agarwal","year":"2009","journal-title":"J Neurosurg Spine"},{"issue":"6 Suppl.","key":"10.1016\/j.spinee.2017.06.023_bib0030","doi-asserted-by":"crossref","first-page":"240S","DOI":"10.1016\/j.spinee.2005.02.014","article-title":"Bone morphogenetic proteins for spinal fusion","volume":"5","author":"Carlisle","year":"2005","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/08977199209046403","article-title":"Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells","volume":"7","author":"Israel","year":"1992","journal-title":"Growth Factors"},{"key":"10.1016\/j.spinee.2017.06.023_bib0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0168-1656(01)00425-4","article-title":"Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli","volume":"94","author":"Vallejo","year":"2002","journal-title":"J Biotechnol"},{"key":"10.1016\/j.spinee.2017.06.023_bib0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1054\/bjom.2000.0533","article-title":"Bone induction by Escherichia coli-derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2","volume":"38","author":"Bessho","year":"2000","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.spinee.2017.06.023_bib0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10529-007-9501-8","article-title":"Osteoinduction in human fat-derived stem cells by recombinant human bone morphogenetic protein-2 produced in Escherichia coli","volume":"30","author":"Bessa","year":"2008","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.spinee.2017.06.023_bib0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/028443100750059057","article-title":"Bone-inductive efficacy of recombinant human bone morphogenetic protein-2 expressed in Escherichia coli: an experimental study in rat mandibular defects","volume":"34","author":"Kimura","year":"2000","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"key":"10.1016\/j.spinee.2017.06.023_bib0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00774-009-0040-3","article-title":"Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing","volume":"27","author":"Yano","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.spinee.2017.06.023_bib0065","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1016\/j.biomaterials.2010.01.075","article-title":"The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli","volume":"31","author":"Lee","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.spinee.2017.06.023_bib0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/bit.10906","article-title":"Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration","volume":"85","author":"Vallejo","year":"2004","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.spinee.2017.06.023_bib0075","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.addr.2003.08.010","article-title":"Collagen sponges for bone regeneration with rhBMP-2","volume":"55","author":"Geiger","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.spinee.2017.06.023_bib0080","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s10856-013-4967-5","article-title":"Effects of porous beta-tricalcium phosphate-based ceramics used as an E. coli-derived rhBMP-2 carrier for bone regeneration","volume":"24","author":"Lee","year":"2013","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.spinee.2017.06.023_bib0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.spinee.2012.01.013","article-title":"Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier","volume":"12","author":"Lee","year":"2012","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0090","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/01.brs.0000172157.39513.80","article-title":"Initial fusion rates with recombinant human bone morphogenetic protein-2\/compression resistant matrix and a hydroxyapatite and tricalcium phosphate\/collagen carrier in posterolateral spinal fusion","volume":"30","author":"Glassman","year":"2005","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2017.06.023_bib0095","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1097\/BRS.0000000000000007","article-title":"rhBMP-2 for posterolateral instrumented lumbar fusion: a multicenter prospective randomized controlled trial","volume":"38","author":"Hurlbert","year":"2013","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2017.06.023_bib0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1302\/0301-620X.95B2.29466","article-title":"Evaluation of the efficacy of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in a mini-pig spinal anterior interbody fusion model","volume":"95-B","author":"Hwang","year":"2013","journal-title":"Bone Joint J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0105","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.spinee.2014.06.007","article-title":"Posterolateral lumbar fusion using Escherichia coli-derived rhBMP-2\/hydroxyapatite in the mini pig","volume":"14","author":"Kong","year":"2014","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1902\/jop.2012.110369","article-title":"Comparative study of Chinese hamster ovary cell versus Escherichia coli-derived bone morphogenetic protein-2 using the critical-size supraalveolar peri-implant defect model","volume":"84","author":"Lee","year":"2013","journal-title":"J Periodontol"},{"key":"10.1016\/j.spinee.2017.06.023_bib0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/ten.tea.2010.0408","article-title":"Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2 in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morphogenetic protein-2","volume":"17","author":"Kim","year":"2011","journal-title":"Tissue Eng Part A."},{"key":"10.1016\/j.spinee.2017.06.023_bib0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/01480545.2013.806530","article-title":"The short-term effects of repetitive E. coli-derived rhBMP-2 administration through intravenous injection in rats","volume":"37","author":"Lee","year":"2014","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.spinee.2017.06.023_bib0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4184\/asj.2014.8.2.113","article-title":"Acute intravenous injection toxicity study of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in rat","volume":"8","author":"Lee","year":"2014","journal-title":"Asian Spine J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2106\/JBJS.L.00137","article-title":"The effect of recombinant human bone morphogenetic protein-2 in single-level posterior lumbar interbody arthrodesis","volume":"95","author":"Michielsen","year":"2013","journal-title":"J Bone Joint J Am"},{"key":"10.1016\/j.spinee.2017.06.023_bib0135","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00256-014-1917-3","article-title":"MRI of transforaminal lumbar interbody fusion: imaging appearance with and without the use of human recombinant bone morphogenetic protein-2 (rhBMP-2)","volume":"43","author":"Fox","year":"2014","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.spinee.2017.06.023_bib0140","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.spinee.2013.07.028","article-title":"Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion","volume":"13","author":"Singh","year":"2013","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.spinee.2007.01.011","article-title":"Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases","volume":"7","author":"Lewandrowski","year":"2007","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0150","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1302\/0301-620X.89B3.18270","article-title":"Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence","volume":"89","author":"Vaidya","year":"2007","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.spinee.2017.06.023_bib0155","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1227\/01.NEU.0000369517.21018.F2","article-title":"Formation of painful seroma and edema after the use of recombinant human bone morphogenetic protein-2 in posterolateral lumbar spine fusions","volume":"66","author":"Garrett","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.spinee.2017.06.023_bib0160","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.spinee.2011.04.023","article-title":"A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0165","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/BRS.0000000000001228","article-title":"Use of recombinant human bone morphogenetic protein-2 in the treatment of degenerative spondylolisthesis","volume":"41","author":"Schroeder","year":"2016","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2017.06.023_bib0170","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1055\/s-0036-1571284","article-title":"Change in off-label use of bone morphogenetic protein in spine surgery and associations with adverse outcome","volume":"6","author":"Poeran","year":"2016","journal-title":"Global Spine J."},{"key":"10.1016\/j.spinee.2017.06.023_bib0175","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.spinee.2011.02.013","article-title":"Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0180","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.spinee.2012.09.040","article-title":"Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study","volume":"12","author":"Comer","year":"2012","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0185","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1007\/s00586-015-3870-9","article-title":"Complications and cancer rates in spine fusion with recombinant human bone morphogenetic protein-2 (rhBMP-2)","volume":"25","author":"Vavken","year":"2016","journal-title":"Eur Spine J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0190","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00586-011-2113-y","article-title":"RhBMP-2 use in lumbar fusion surgery is associated with transient immediate post-operative leg pain","volume":"21","author":"Rowan","year":"2012","journal-title":"Eur Spine J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.spinee.2013.06.109","article-title":"Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study","volume":"14","author":"Lykissas","year":"2014","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0200","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.spinee.2013.06.022","article-title":"Complications of rhBMP-2 utilization for posterolateral lumbar fusions requiring reoperation: a single practice, retrospective case series report","volume":"13","author":"Hoffmann","year":"2013","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2017.06.023_bib0205","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00264-016-3149-8","article-title":"Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review","volume":"40","author":"Faundez","year":"2016","journal-title":"Int Orthop"},{"key":"10.1016\/j.spinee.2017.06.023_bib0210","doi-asserted-by":"crossref","first-page":"E277","DOI":"10.1097\/BSD.0b013e318287f2e2","article-title":"Adverse events with the use of rhBMP-2 in thoracolumbar and lumbar spine fusions: a 9-year institutional analysis","volume":"28","author":"Lubelski","year":"2015","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.spinee.2017.06.023_bib0215","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1097\/BRS.0000000000001184","article-title":"Bone morphogenetic proteins in spinal surgery: what is the fusion rate and do they cause cancer?","volume":"40","author":"Malham","year":"2015","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2017.06.023_bib0220","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/BRS.0b013e3182a3d3b4","article-title":"Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2)","volume":"38","author":"Cooper","year":"2013","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2017.06.023_bib0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40824-015-0039-x","article-title":"Rapid bone regeneration by Escherichia coli-derived recombinant human bone morphogenetic protein-2 loaded on a hydroxyapatite carrier in the rabbit calvarial defect model","volume":"19","author":"Chung","year":"2015","journal-title":"Biomater Res"},{"key":"10.1016\/j.spinee.2017.06.023_bib0230","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00264-014-2301-6","article-title":"Bone union rate with recombinant human bone morphogenic protein-2 versus autologous iliac bone in PEEK cages for anterior lumbar interbody fusion","volume":"38","author":"Flouzat-Lachaniette","year":"2014","journal-title":"Int Orthop"}],"container-title":["The Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943017302917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943017302917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T08:50:34Z","timestamp":1535705434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529943017302917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1529943017302917"],"URL":"https:\/\/doi.org\/10.1016\/j.spinee.2017.06.023","relation":{},"ISSN":["1529-9430"],"issn-type":[{"value":"1529-9430","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial","name":"articletitle","label":"Article Title"},{"value":"The Spine Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spinee.2017.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}